ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Ophthalmology

Top Ophthalmology Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JEFFREY KAMMER MD

Ophthalmology

5,247

$417K

619
523 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

58%
prescriptions for brand name drugs

Avg: 55%

$80
Average prescription price

Avg: $67

CHARLES LINDSEY MD

Ophthalmology

5,034

$295K

1078
960 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

48%
prescriptions for brand name drugs

Avg: 55%

$59
Average prescription price

Avg: $67

RICHARD CAPE MD

Ophthalmology

4,963

$251K

1269
1100 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

65%
prescriptions for brand name drugs

Avg: 55%

$51
Average prescription price

Avg: $67

MICHAEL SHAHBAZI MD

Ophthalmology

4,792

$330K

816
737 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

58%
prescriptions for brand name drugs

Avg: 55%

$69
Average prescription price

Avg: $67

RONALD MCFARLAND M.D.

Ophthalmology

4,438

$251K

582
486 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

50%
prescriptions for brand name drugs

Avg: 55%

$57
Average prescription price

Avg: $67

JASON SULLIVAN MD

Ophthalmology

4,402

$218K

707
613 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

53%
prescriptions for brand name drugs

Avg: 55%

$50
Average prescription price

Avg: $67

JOHN LINN M.D.

Ophthalmology

4,254

$368K

1002
865 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

71%
prescriptions for brand name drugs

Avg: 55%

$86
Average prescription price

Avg: $67

JAMES BATTLE M.D.

Ophthalmology

4,205

$255K

593
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

53%
prescriptions for brand name drugs

Avg: 55%

$61
Average prescription price

Avg: $67

THOMAS BROWNING M.D.

Ophthalmology

4,058

$156K

1263
1115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

24%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

56%
prescriptions for brand name drugs

Avg: 55%

$38
Average prescription price

Avg: $67

ROWLAND HAWKINS M.D.

Ophthalmology

3,977

$156K

658
605 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

33%
prescriptions for brand name drugs

Avg: 55%

$39
Average prescription price

Avg: $67

JAMES LODEN M.D.

Ophthalmology

3,794

$163K

1043
908 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 5%

20%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

42%
prescriptions for brand name drugs

Avg: 55%

$43
Average prescription price

Avg: $67

JEFFREY BUNNING M.D.

Ophthalmology

3,682

$208K

924
768 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

53%
prescriptions for brand name drugs

Avg: 55%

$57
Average prescription price

Avg: $67

BEN MAHAN M.D.

Ophthalmology

3,661

$271K

532
473 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

58%
prescriptions for brand name drugs

Avg: 55%

$74
Average prescription price

Avg: $67

DAVID HARRIS M.D.

Ophthalmology

3,629

$164K

806
697 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

45%
prescriptions for brand name drugs

Avg: 55%

$45
Average prescription price

Avg: $67

CHARLES BICE MD

Ophthalmology

3,605

$225K

822
721 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

51%
prescriptions for brand name drugs

Avg: 55%

$62
Average prescription price

Avg: $67

ANTHONY SEATON MD, PHD

Ophthalmology

3,400

$222K

926
865 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

64%
prescriptions for brand name drugs

Avg: 55%

$65
Average prescription price

Avg: $67

JOSEPH ARMSTRONG M.D.

Ophthalmology

3,190

$163K

853
741 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

17%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

51%
prescriptions for brand name drugs

Avg: 55%

$51
Average prescription price

Avg: $67

SUBBA GOLLAMUDI M.D.

Ophthalmology

3,177

$259K

810
679 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 5%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

74%
prescriptions for brand name drugs

Avg: 55%

$81
Average prescription price

Avg: $67

CRAIG MCCABE MD

Ophthalmology

3,166

$295K

536
470 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

72%
prescriptions for brand name drugs

Avg: 55%

$93
Average prescription price

Avg: $67

JOHN DAWSON M.D.

Ophthalmology

3,158

$190K

697
648 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

56%
prescriptions for brand name drugs

Avg: 55%

$60
Average prescription price

Avg: $67

RANDOLPH EVANS MD

Ophthalmology

3,048

$188K

460
395 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

52%
prescriptions for brand name drugs

Avg: 55%

$62
Average prescription price

Avg: $67

THOMAS REYNOLDS M.D.

Ophthalmology

3,047

$245K

779
741 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

57%
prescriptions for brand name drugs

Avg: 55%

$81
Average prescription price

Avg: $67

JAMES SAVAGE M.D.

Ophthalmology

2,885

$228K

472
376 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

60%
prescriptions for brand name drugs

Avg: 55%

$79
Average prescription price

Avg: $67

JOHN MILLER M.D.

Ophthalmology

2,857

$283K

659
613 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

66%
prescriptions for brand name drugs

Avg: 55%

$99
Average prescription price

Avg: $67

ROBERT PILKINTON M.D.

Ophthalmology

2,842

$169K

543
504 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

46%
prescriptions for brand name drugs

Avg: 55%

$59
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank